Abstract:Although participation of IL-6 in lung inflammation has been widely elucidated, the transcriptional regulation of its generation in alveolar type II cells stimulated by TNF-alpha remain unclear. Here, we find that TNF-alpha significantly induces IL-6 production, and TNF-alpha induction of IL-6 is mainly regulated at transcriptional level. Upon stimulated by TNF-alpha, Activator Protein-1 (AP-1)-mediated transcriptional activity is apparently increased in alveolar type II epithelial cells, which might be derived from elevated phosphorylation of JNK and subsequent activation of c-Jun. Either down-regulation of c-Jun or the AP-1 site mutation leads to significant reduction of IL-6 expression. In contrast, ectopic expression of c-Jun notably increases IL-6 generation. So, c-Jun, one of the AP-1 family members, plays a pivotal role in TNF-alpha-induced IL-6 generation. CCAAT/enhancer binding protein delta (C/EBP delta) expression is significantly amplified by TNF-alpha, which may contribute to the rise of C/EBP activity in alveolar type II cells. C/EBP delta shRNA treatment results in attenuation of IL-6 expression in the cells, which is consistent with data by introduction of mutations into the C/EBP site in the promoter. However, overexpression of C/EBP delta greatly increases the IL-6 promoter activity. In addition, data regarding another transactivator in the family-C/EBP beta show that it does not affect IL-6 production. We also find that the IKK/NF-kappa B p65 pathway is activated in TNF-alpha-treated alveolar type II epithelial cells, and plays an essential role in positive regulation of IL-6 expression in TNF-alpha-treated alveolar type II epithelial cells via knockdown or forced expression of NF-kappa B p65, or elimination of xB sites in the IL-6 promoter. Notably, IL-6 promoter-driven luciferase production in primary alveolar type II epithelial cells can also be increased by the ectopic expression of c-Jun, C/EBP delta, and NF-kappa B p65, respectively. Collectively, our data provide insights into molecular mechanism involved in IL-6 expression in alveolar type II epithelial cells on TNF-alpha treatment, which provides a theoretical basis for specific inhibition of IL-6 production at the transcriptional level.

Nucleocapsid protein of SARS-CoV activates interleukin-6 expression through cellular transcription factor NF-κB

Tnf-Alpha Induction Of Il-6 In Alveolar Type Ii Epithelial Cells: Contributions Of Jnk/C-Jun/Ap-1 Element, C/Ebp Delta/C/Ebp Binding Site And Ikk/Nf-Kappa B P65/Kappa B Site

SARS-CoV-2 N Protein Induces Acute Lung Injury in Mice <i>via</i> NF-B Activation

SARS-CoV-2 N Protein Triggers Acute Lung Injury Via Modulating Macrophage Activation and Infiltration in in Vitro and in Vivo

Overly Exuberant Innate Immune Response to SARS-CoV-2 Infection

Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-κB Activation

SARS-CoV-2 Nsp5 Activates NF-κB Pathway by Upregulating SUMOylation of MAVS

SARS-CoV-2 NSP16 promotes IL-6 production by regulating the stabilization of HIF-1α

Regulation of Proinflammatory Cytokine Interleukin-6 (IL-6) Induction by NF-kappaB Signaling in Pandemic H1N1 Influenza A Virus-Infected Human Bronchial Epithelial Cells (45.29)

Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus

RNA-induced Liquid Phase Separation of SARS-CoV-2 Nucleocapsid Protein Facilitates NF-κB Hyper-Activation and Inflammation.

SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway

A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response

SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation

Signaling mechanisms of SARS-CoV-2 Nucleocapsid protein in viral infection, cell death and inflammation

Phage Display Technique Identifies the Interaction of Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame 6 Protein with Nuclear Pore Complex Interacting Protein NPIPB3 in Modulating Type I Interferon Antagonism

Severe Acute Respiratory Syndrome-associated Coronavirus Nucleocapsid Protein Interacts with Smad3 and Modulates Transforming Growth Factor-β Signaling

A SARS-CoV Protein, ORF-6, Induces Caspase-3 Mediated, ER Stress and JNK-dependent Apoptosis.

SARS-CoV-2 nucleocapsid protein, rather than spike protein, triggers a cytokine storm originating from lung epithelial cells in patients with COVID-19

SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response

SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production